News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Valneva has started a Phase 1/2 trial of its COVID-19 vaccine: eying up potential regulatory approval in the fourth quarter of 2021. It champions a ‘tried and tested’ approach with its inactivated candidate.
The President of the European Commission, Ursula von der Leyen, says COVID-19 vaccinations in the European Union will start at the end of the month.
New Zealand now has enough COVID-19 vaccines for everyone in the country, says the government, as it announces two new supply agreements with Novavax and AstraZeneca today.